AXIM insider filings

AXIM BIOTECHNOLOGIES, INC. — 24 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-10-15. Screen AXIM transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for AXIM between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — AXIM BIOTECHNOLOGIES, INC.

FiledFormInsiderReported transactionsSource
2024-10-154Valencia Catalina — President and Director, Director, 10% ownerPurchase (P): 1,086,216EDGAR
2024-03-194Valencia Catalina — 10% ownerGrant/award (A): 7,837,500 (derivative) @ $156,750EDGAR
2024-03-194Schroeder Blake — DirectorGrant/award (A): 35,000 (derivative) @ $35,000EDGAR
2024-03-194Cunningham Robert L — DirectorGrant/award (A): 35,000 (derivative) @ $35,000EDGAR
2024-03-194Scott Timothy Richard — DirectorGrant/award (A): 35,000 (derivative) @ $35,000EDGAR
2024-03-194O'Rourke Peter — DirectorGrant/award (A): 35,000 (derivative) @ $35,000EDGAR
2024-03-194HUEMOELLER JOHN WALTER II — Chief Executive Officer, DirectorGrant/award (A): 1 (derivative) @ $250,000EDGAR
2024-03-194/AHUEMOELLER JOHN WALTER II — Chief Executive Officer, DirectorGrant/award (A): 250,000 (derivative) @ $250,000 · Grant/award (A): 250,000 (derivative) @ $250,000EDGAR
2024-03-194MALASEK ROBERT — Chief Financial OfficerGrant/award (A): 53,500 (derivative) @ $53,500EDGAR
2022-09-234Scott Timothy Richard — DirectorGrant/award (A): 500,000 (derivative) @ $0EDGAR
2022-09-234Schroeder Blake — DirectorGrant/award (A): 1,000,000 (derivative) @ $0EDGAR
2022-09-234MALASEK ROBERT — Chief Financial OfficerGrant/award (A): 300,000 (derivative) @ $0EDGAR
2022-09-234Cunningham Robert L — DirectorGrant/award (A): 1,000,000 (derivative) @ $0EDGAR
2022-09-234Cunningham Robert L — DirectorGrant/award (A): 500,000 (derivative) @ $0EDGAR
2022-09-234Scott Timothy Richard — DirectorGrant/award (A): 1,000,000 (derivative) @ $0EDGAR
2022-09-234HUEMOELLER JOHN WALTER II — Chief Executive Officer, DirectorGrant/award (A): 5,000,000 (derivative) @ $0EDGAR
2022-09-234HUEMOELLER JOHN WALTER II — Chief Executive Officer, DirectorDisposition to issuer (D): 2,000,000 (derivative) @ $0EDGAR
2022-09-234HUEMOELLER JOHN WALTER II — Chief Executive Officer, DirectorGrant/award (A): 3,000,000 (derivative) @ $0EDGAR
2022-09-234HUEMOELLER JOHN WALTER II — Chief Executive Officer, DirectorPurchase (P): 6,000,000EDGAR
2022-09-234HUEMOELLER JOHN WALTER II — Chief Executive Officer, DirectorGrant/award (A): 2,000,000 (derivative) @ $0EDGAR
2022-09-234MALASEK ROBERT — Chief Financial OfficerGrant/award (A): 500,000 (derivative) @ $0EDGAR
2022-08-314Valencia Catalina — 10% ownerPurchase (P): 3,861,004 @ $0.03EDGAR
2022-08-264Schroeder Blake — DirectorConversion (C): 854,012 @ $0.03EDGAR
2022-02-154Schroeder Blake — DirectorOther (J): 25,000 (derivative) @ $25,000EDGAR

Recent 8-K events — AXIM BIOTECHNOLOGIES, INC.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2024-10-158-K5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
EDGAR
2024-03-218-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9.01 — Financial Statements and Exhibits
EDGAR
2024-02-138-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
EDGAR
2023-12-288-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
2023-06-028-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2023-05-308-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9.01 — Financial Statements and Exhibits
EDGAR
2023-05-258-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2023-01-278-K1.01 — Entry into a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9.01 — Financial Statements and Exhibits
EDGAR
2022-09-198-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2022-08-298-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=AXIM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs